340 related articles for article (PubMed ID: 10564065)
1. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers.
Liu DZ; Morris-Natschke SL; Kucera LS; Ishaq KS; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1169-74. PubMed ID: 10564066
[TBL] [Abstract][Full Text] [Related]
3. The effect of hyperosmosis on paracellular permeability in Caco-2 cell monolayers.
Inokuchi H; Takei T; Aikawa K; Shimizu M
Biosci Biotechnol Biochem; 2009 Feb; 73(2):328-34. PubMed ID: 19202294
[TBL] [Abstract][Full Text] [Related]
4. [Effect of self-microemulsifying system on cell tight junctions].
Sha XY; Fang XL
Yao Xue Xue Bao; 2006 Jan; 41(1):30-5. PubMed ID: 16683524
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonists.
Gan LS; Yanni S; Thakker DR
Pharm Res; 1998 Jan; 15(1):53-7. PubMed ID: 9487546
[TBL] [Abstract][Full Text] [Related]
6. Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells.
Duizer E; van der Wulp C; Versantvoort CH; Groten JP
J Pharmacol Exp Ther; 1998 Oct; 287(1):395-402. PubMed ID: 9765361
[TBL] [Abstract][Full Text] [Related]
7. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
8. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
Musch MW; Walsh-Reitz MM; Chang EB
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
[TBL] [Abstract][Full Text] [Related]
9. The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line.
Yu Q; Wang Z; Li P; Yang Q
Drug Dev Ind Pharm; 2013 Apr; 39(4):587-92. PubMed ID: 22656319
[TBL] [Abstract][Full Text] [Related]
10. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells.
Sha X; Yan G; Wu Y; Li J; Fang X
Eur J Pharm Sci; 2005 Apr; 24(5):477-86. PubMed ID: 15784337
[TBL] [Abstract][Full Text] [Related]
11. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size.
Knipp GT; Ho NF; Barsuhn CL; Borchardt RT
J Pharm Sci; 1997 Oct; 86(10):1105-10. PubMed ID: 9344165
[TBL] [Abstract][Full Text] [Related]
12. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1336-45. PubMed ID: 17373574
[TBL] [Abstract][Full Text] [Related]
13. Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.
Kamath AV; Morrison RA; Mathias NR; Dando SA; Marino AM; Chong S
Arch Pharm Res; 2007 Aug; 30(8):1002-7. PubMed ID: 17879754
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship for enhancement of paracellular permeability across Caco-2 cell monolayers by 3-alkylamido-2-alkoxypropylphosphocholines.
Ouyang H; Morris-Natschke SL; Ishaq KS; Ward P; Liu D; Leonard S; Thakker DR
J Med Chem; 2002 Jun; 45(13):2857-66. PubMed ID: 12061888
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer AG; Verhoef JC; Junginger HE
J Control Release; 1998 Jan; 51(1):35-46. PubMed ID: 9685902
[TBL] [Abstract][Full Text] [Related]
16. Intestinal absorption of miltefosine: contribution of passive paracellular transport.
Ménez C; Buyse M; Dugave C; Farinotti R; Barratt G
Pharm Res; 2007 Mar; 24(3):546-54. PubMed ID: 17252190
[TBL] [Abstract][Full Text] [Related]
17. Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers.
Doi N; Tomita M; Hayashi M
Drug Metab Pharmacokinet; 2011; 26(2):162-70. PubMed ID: 21206134
[TBL] [Abstract][Full Text] [Related]
18. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
Moran GW; O'Neill C; McLaughlin JT
Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells.
Hossain Z; Kurihara H; Hosokawa M; Takahashi K
Mol Cell Biochem; 2006 Apr; 285(1-2):155-63. PubMed ID: 16477371
[TBL] [Abstract][Full Text] [Related]
20. Biorelevant refinement of the Caco-2 cell culture model to assess efficacy of paracellular permeability enhancers.
Tippin TK; Thakker DR
J Pharm Sci; 2008 May; 97(5):1977-92. PubMed ID: 17724658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
